Skip to main content
. 2022 May 4;11:9. doi: 10.4103/jos.jos_170_21

Table 1.

Characteristics of included articles

Author Type of study Participants/studies included Control and experimental group Duration Level of evidence*
Azeem M and Hamid W (2017)[9] Prospective Study a. 25 participants
b. 13 females, 12 males were recruited
c. Mean age±standard deviation16.17±1.76 years
Experimental Group- CA 18.11±5.12 months 3
Alshatti et al. (2017)[13] Randomized Clinical Trial
Block randomization generated by computer software “RandomAllocation Software”
Single blinding
a. 60 participants
b. There were more males than females in the three groups. Data not specified
c. Mean age±standard deviation
Group 1=(21.44±11.62 years)
Group 2=(14.82±4.26 years)
Group 3=(14.47±3.99 years)
a. Control Group- None
b. Experimental Group-
Group 1- CA
Group 2- SLB
Group 3- FA
18 months
T0=at the beginning of treatment
T1=18 months
2
Buschang et al. (2019)[14] Retrospective Cohort Study a. 450 participants,
Group 1=244,
Group 2=206
b. No data on the sex ratio.
c. Mean age±standard deviation
Group 1=30.4±14 years
Group 2=29.2±11.5 years
a. Control Group- None
b. Experimental Group-
Group 1- CA (244)
Group 2- FA (206)
Not mentioned 3
Karad et al.(2019)[15] Narrative Review Article Research articles, systematic reviews, and meta-analyses were used for the preparation of this narrative review corresponding to human subjects Not applicable Studies till September 2018 were included 5
Albhaisi et al (2020)[16] Randomized clinical trial.
Simple randomization (COIN TOSS)
Blinding was done only in data assessment
a. 49 participants were included (42 completed the study)
b. 39 females, 10 males were recruited
Only 23 subjects (6 male and 17 female) in group 1
and 19 subjects (3 male and 16 female) in group 2
c. Mean age±standard deviation - 21.25±3 years
a. Control Group- None
b. Experimental Group-
Group 1- CA (23)
Group 2- FA (19)
3 months
T0=before treatment
T1=after 3 months
2